» Articles » PMID: 28944747

Suicide-related Behaviours in Schizophrenia in China: a Comprehensive Meta-analysis

Overview
Date 2017 Sep 26
PMID 28944747
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Suicide-related behaviours are common in schizophrenia and are significantly associated with premature death. The objective of this meta-analysis study was to estimate the pooled prevalence of suicide-related behaviours in schizophrenia patients in China.

Methods: The relevant literature was searched systematically via the relevant electronic databases (PubMed, Embase, PsycINFO, Chinese National Knowledge Infrastructure, Wanfang Databases and Chinese Biological Medical Literature Database) from their inception until 14 September 2016. Only original studies that reported the prevalence of suicide-related behaviours including suicidal ideation (SI), suicide plan, suicide attempt (SA) and completed suicide were selected.

Results: Nineteen articles met the inclusion criteria and were analysed. The pooled lifetime prevalence of SI and SA were 25.8% (95% CI 14.7-41.1%) and 14.6% (95% CI 9.1-22.8%), respectively. The 1-month prevalence of SI was 22.0% (95% CI 18.2-26.4%). Subgroup analyses of lifetime SI and SA showed that gender, sample size, survey year, study location and source of patients have no significant mediating effects on the results.

Conclusions: Suicide-related behaviours are common in Chinese schizophrenia patients. Due to the high mortality risk, regular screening and effective suicide prevention programmes are warranted.

Citing Articles

Suicide Risk and Its Associations with Psychiatric Symptoms and Sleep Disturbances in Schizophrenia Inpatients - Henan, Hebei, and Shandong Provinces and Beijing Municipality, China, 2019-2022.

Li C, Chen Y, Zhang L, Zhang H, Zhang S, Chen Q China CDC Wkly. 2025; 7(5):176-183.

PMID: 39974353 PMC: 11832453. DOI: 10.46234/ccdcw2025.028.


Gender-specific correlates for suicide mortality in people with schizophrenia: a 9-year population-based study.

Pan Z, Zhou L, Chen Y, Su J, Duan X, Zhong S BMC Psychiatry. 2024; 24(1):692.

PMID: 39415139 PMC: 11481785. DOI: 10.1186/s12888-024-06089-0.


Can neurocognition, brain neurotrophic factor, triglyceride, and total cholesterol predict suicidal ideation in first-episode Han Chinese patients with schizophrenia?.

Dongxia L, Li M, Yingying F Brain Behav. 2024; 14(5):e3499.

PMID: 38680078 PMC: 11056701. DOI: 10.1002/brb3.3499.


Molecular Changes Associated with Suicide.

Navarro D, Marin-Mayor M, Gasparyan A, Garcia-Gutierrez M, Rubio G, Manzanares J Int J Mol Sci. 2023; 24(23).

PMID: 38069051 PMC: 10706600. DOI: 10.3390/ijms242316726.


Prevalence and factors associated with suicide attempts among Moroccan patients with schizophrenia: cross-sectional study.

Koubaa I, Aden M, Barrimi M Ann Med Surg (Lond). 2023; 85(6):2528-2533.

PMID: 37363523 PMC: 10289528. DOI: 10.1097/MS9.0000000000000771.


References
1.
Popovic D, Benabarre A, Crespo J, Goikolea J, Gonzalez-Pinto A, Gutierrez-Rojas L . Risk factors for suicide in schizophrenia: systematic review and clinical recommendations. Acta Psychiatr Scand. 2014; 130(6):418-26. DOI: 10.1111/acps.12332. View

2.
Hunt I, Kapur N, Windfuhr K, Robinson J, Bickley H, Flynn S . Suicide in schizophrenia: findings from a national clinical survey. J Psychiatr Pract. 2006; 12(3):139-47. DOI: 10.1097/00131746-200605000-00002. View

3.
Cao X, Zhong B, Xiang Y, Ungvari G, Lai K, Chiu H . Prevalence of suicidal ideation and suicide attempts in the general population of China: A meta-analysis. Int J Psychiatry Med. 2015; 49(4):296-308. PMC: 4536918. DOI: 10.1177/0091217415589306. View

4.
Krupinski M, Fischer A, Grohmann R, Engel R, Hollweg M, Moller H . [Schizophrenic psychoses and suicide in the clinic. Risk factors, psychopharmacologic treatment]. Nervenarzt. 2000; 71(11):906-11. DOI: 10.1007/s001150050682. View

5.
Crisp A, Gelder M, Goddard E, Meltzer H . Stigmatization of people with mental illnesses: a follow-up study within the Changing Minds campaign of the Royal College of Psychiatrists. World Psychiatry. 2006; 4(2):106-13. PMC: 1414750. View